Equities

Vivos Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
RDGL:QBB

Vivos Inc

Actions
Basic MaterialsChemicals
  • Price (USD)0.0779
  • Today's Change0.003 / 3.87%
  • Shares traded1.48m
  • 1 Year change-47.01%
  • Beta-0.6197
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.

  • Revenue in USD (TTM)48.63k
  • Net income in USD-3.01m
  • Incorporated2000
  • Employees10.00
  • Location
    Vivos Inc719 Jadwin AveRICHLAND 99352-4217United StatesUSA
  • Phone+1 (509) 736-4000
  • Fax+1 (509) 736-4007
  • Websitehttps://www.radiogel.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Baird Medical Investment Holdings Ltd31.86m-3.12m28.28m143.00--0.5745--0.8876-0.1128-0.11281.221.340.45523.270.8459222,797.30-4.48---7.64--86.94---9.84--1.67-0.3230.3856--17.74--18.57------
Femasys Inc2.06m-19.80m29.72m69.00--5.28--14.42-0.7198-0.71980.070.09630.12940.19734.3429,876.81-124.24-63.09-214.46-74.3063.0566.63-960.53-961.820.6131-9.720.5982--51.9711.89-32.07--4.01--
Myomo Inc41.64m-12.02m31.53m184.00--2.16--0.7571-0.2885-0.28851.010.38051.653.969.23226,321.70-47.71-55.96-70.30-77.4066.5669.74-28.86-52.922.10--0.2148--69.1753.3624.10--92.10--
Vaso Corp89.11m2.59m31.67m298.0012.261.129.560.35540.01470.01470.50650.16051.1334.0210.28299,030.203.277.375.3614.5660.9159.172.915.991.61--0.01--7.092.82-80.21--3.81--
EUDA Health Holdings Ltd5.16m-2.06m31.76m117.0054.37----6.150.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Ekso Bionics Holdings Inc14.75m-10.66m33.49m61.00--2.67--2.27-5.70-5.707.253.690.57991.362.27241,786.90-41.02-41.01-60.62-52.9053.4852.89-70.74-97.041.09--0.3055---1.945.1925.45---9.22--
RenovoRx Inc928.00k-11.11m34.21m10.00--4.23--36.86-0.4375-0.43750.03120.22040.0874----92,800.00-104.58-121.57-126.33-166.5067.78---1,196.66-90,830.235.68--0.00------13.86------
TELA Bio Inc77.06m-39.00m34.54m209.00--20.45--0.4483-0.8863-0.88631.750.03861.342.016.85368,684.20-68.06-51.29-96.57-60.7067.2366.26-50.61-88.022.62-7.250.9638--18.5635.0218.91---18.18--
Modular Medical Inc0.00-24.22m35.22m54.00--3.16-----0.5081-0.50810.000.14340.00----0.00-222.79-171.42-294.38-207.14------------0.00-------7.75--57.07--
Vivos Inc48.63k-3.01m35.42m10.00--16.25--728.32-0.0068-0.00680.00010.00480.0275--10.03---170.12-166.49-178.25-242.01-127.332.81-6,191.01-11,105.9819.81--0.00--43.5924.13-0.5424------
Precision Optics Corporation Inc21.58m-6.11m36.75m90.00--3.36--1.70-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
Icecure Medical Ltd2.98m-15.29m39.31m64.00--4.22--13.21-0.2586-0.25860.05010.13490.1960.823524.3946,484.38-100.74-61.14-155.92-77.1135.0650.17-513.95-343.951.90--0.00--1.9215.35-4.55---6.51--
Cytosorbents Corp34.35m-10.59m40.28m149.00--4.47--1.17-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Precipio Inc22.80m-1.25m40.98m54.00--2.97169.341.80-0.835-0.83514.637.881.2018.2615.31422,222.20-6.58-38.01-8.60-46.9844.8233.80-5.50-71.341.10-24.190.074--21.9542.7426.70--32.31--
Neuroone Medical Technologies Corp12.10m-3.61m41.01m18.00--5.75--3.39-0.0784-0.07840.30120.14141.501.6316.79672,094.40-44.63-113.64-61.95-152.0867.3060.94-29.80-223.443.47--0.1519--250.3544.4170.73---7.76--
electroCore, Inc.29.84m-14.16m43.42m73.00------1.46-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Data as of Feb 13 2026. Currency figures normalised to Vivos Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.